TME Pharma Signs Exclusive, Binding Negotiation Agreement With Japan’s TMS
TME Pharma said it signed an exclusive, binding negotiation agreement with Japan-based TMS Co., Ltd.
Related stories
KOSPI Falls More Than 3% as AI Profitability Worries and Foreign Selling Weigh
The KOSPI fell more than 3% at the close, with AI profitability concerns and foreign selling cited; the index was down 16% for the month.
M impact | EQUITY | Oct 30, 2026, 06:43 AM UTC
Amazon Reports Fiscal Q3 Profit of 1136亿美元, Up 101.12%
Amazon reported fiscal third-quarter profit attributable to shareholders of 1136亿美元, up 101.12% year over year, with basic EPS of 10.55美元.
M impact | EQUITY | Oct 30, 2026, 06:43 AM UTC
Intel Shares Plunge 23% on Production Bottlenecks, Negative FCF Outlook
H impact | EQUITY | Oct 30, 2026, 06:42 AM UTC
Q-linea Q3 Sales Rise, Signs US Healthcare Agreement
Swedish healthcare company Q-linea reported higher third-quarter sales and a new US healthcare agreement.
M impact | EQUITY | Oct 30, 2026, 06:42 AM UTC
Loomis Q3 Revenue Slightly Misses Estimates
Sweden's Loomis reported Q3 revenue slightly below estimates.
M impact | EQUITY | Oct 30, 2026, 06:42 AM UTC
Ueda Says BOJ Will Not Change J-REIT Sales Pace
BOJ Governor Kazuo Ueda said the central bank will make no change to the pace of its J-REIT sales.
M impact | EQUITY | Oct 30, 2026, 06:41 AM UTC